Clinical Pharmacy and Practice

Permanent URI for this collection

http://dspace.alquds.edu:4000/handle/20.500.12213/140

Overview

Use of HbA1c to diagnose type 2 diabetes Mellitus. Gestational diabetes and adverse pregnancy outcome is under investigation. Type 2 diabetes in children will be investigated in schools. A platform will be developed to follow up risk factors like obesity, lack of exercise, unhealty food and genetics. The program will highlight the risk factors for each students to be used by parents, Ministry of Education, Ministry of Health and School administration to overcome these risk factors and to treat those who developed diabetes.

Our Team

    • Maher Khdour

    Ph.D.

    • Ahmad Amro

    Ph.D.

    Hussein Hallak

    Ph.D.

    Rania Ghanem

    Ph.D.

    Browse

    Browsing Clinical Pharmacy and Practice by Author "Hallak, Hussein"

    Now showing 1 - 1 of 1
    • Thumbnail Image
      Item
      Pharmacovigilance and Adverse Drug Reactions Reporting Process in West-Bank, Palestine
      (Deanship of Scientific Research at An Najah National University, 2016-10-09) Khdour, Maher; Yaghmour, Nima; Hallak, Hussein; Dweib, Mohammad; Al-Shahed, Qusai; Jarab, Anan
      Active national pharmacovigilance programmes are needed to monitor adverse drug reaction (ADR) data in local populations. The objective of this study was to describe the knowledge, experiences, attitudes and perceived barriers to reporting of suspected ADRs by community and hospital pharmacists in West Bank, Palestine. Between December 2014 and March 2015 we conducted a survey about the knowledge and attitude of pharmacists (n = 270) using a face-to-face questionnaire. The questionnaire consisted of questions about the sociodemographic characteristics of the pharmacists, their knowledge of pharmacovigilance and their attitudes towards ADR reporting. Main outcomes measured: The majority of the pharmacists (62.6%) worked in the community pharmacies and more females responded to the questionnaire than males (59% vs 41%). only 11.9% could conceptually or actually define ‘pharmacovigilance’ correctly while one quarter of the respondent pharmacist (24.9%) could define ADR correctly. The hospital clinical pharmacists defined ‘pharmacovigilance’ correctly with higher significance (P<0.001) when compared with community pharmacists. Only 12.2% had ever reported an ADR. The majority of these reports (85%) done by the hospital pharmacists (p<0.0001). The main reasons that discourage the pharmacists from reporting ADRs were ‘‘no enough information available from the patient (76.7%)’’, and ‘‘they did not know how to report (66.7%)’’. The majority of the respondents (92.0%) felt that reporting ADR was their duty and (82%) participants were interested in participating in the National Pharmacovigilance Programme in Palestine. The results show that Palestinian pharmacists have poor knowledge about pharmacovigilance. There is an urgent need for educational programs to train them about pharmacovigilance and ADR reporting scheme.